Aster DM Healthcare Ltd

Aster DM Healthcare Ltd

₹ 750 -0.70%
19 May 3:26 p.m.
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Merger of Aster DM & Quality Care[1]
Aster DM and Blackstone-backed Quality Care are to merge and create one of the top 3 hospital chains in India with 10,360+ beds. The merged listed entity will be named Aster DM Quality Care Limited and will be one of the largest M&A in the hospital space in India based on number of operational beds. Aster acquired a 5.0% stake in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake followed by merger of QCIL into Aster by way of a scheme of amalgamation.
Inter-se shareholding between Aster DM and Quality Care shareholders would be 57.3% and 42.7% respectively. The merger is cash neutral and is expected to be EPS accretive from 1st full year of operations.

  • Market Cap 38,849 Cr.
  • Current Price 750
  • High / Low 770 / 519
  • Stock P/E 95.2
  • Book Value 88.3
  • Dividend Yield 0.66 %
  • ROCE 11.4 %
  • ROE 10.7 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 1,560%

Cons

  • Stock is trading at 8.46 times its book value
  • Company has a low return on equity of 7.23% over last 3 years.
  • Promoters have pledged 40.7% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
807 841 929 955 974 1,002 1,086 1,050 1,000 1,078 1,197 1,186 1,182
687 722 787 805 817 841 869 864 818 876 961 983 958
Operating Profit 120 119 142 149 156 161 217 186 182 202 236 202 224
OPM % 15% 14% 15% 16% 16% 16% 20% 18% 18% 19% 20% 17% 19%
149 -17 -64 153 -40 5,120 35 9 5 29 28 -0 37
Interest 25 25 30 25 30 29 31 31 32 31 31 31 30
Depreciation 54 51 54 57 58 60 62 62 64 63 66 68 67
Profit before tax 190 26 -7 220 28 5,191 159 102 91 136 167 103 163
Tax % 4% 24% 120% 5% 108% 1% 33% 37% 6% 31% 27% 43% 6%
183 20 -15 209 -2 5,152 106 64 86 94 121 59 154
EPS in Rs 3.42 0.10 -0.62 3.59 -0.48 103.00 1.94 1.14 1.58 1.65 2.12 1.01 2.71
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 2,994 3,699 4,138 4,643
3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 2,547 3,124 3,384 3,779
Operating Profit 506 445 349 632 1,077 1,465 1,103 1,533 447 575 754 864
OPM % 13% 8% 6% 9% 14% 17% 13% 15% 15% 16% 18% 19%
23 25 453 177 -155 -158 53 51 353 32 5,169 93
Interest 79 189 371 204 205 391 334 307 96 119 133 123
Depreciation 144 243 322 298 306 586 618 641 192 220 249 264
Profit before tax 306 38 108 308 410 330 205 637 511 268 5,542 570
Tax % 11% 78% 10% 8% 10% 5% 13% 6% 7% 21% 2% 25%
272 8 98 282 367 315 178 601 475 212 5,408 427
EPS in Rs 7.00 0.20 2.52 5.32 6.59 5.54 2.96 10.53 8.51 2.59 107.66 7.49
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 4,637% 5% 40%
Compounded Sales Growth
10 Years: -1%
5 Years: -12%
3 Years: 16%
TTM: 12%
Compounded Profit Growth
10 Years: 48%
5 Years: 23%
3 Years: -1%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: 38%
3 Years: 44%
1 Year: 29%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 7%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 389 403 403 505 505 497 497 500 500 500 500 518
Reserves 1,096 17 1,472 2,327 2,709 2,775 2,875 3,080 3,574 3,686 2,554 4,058
1,091 3,321 2,758 2,352 2,788 5,605 4,804 5,282 6,075 1,758 2,392 2,220
1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,687 12,039 1,154 1,316
Total Liabilities 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,112
2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,052 3,175 3,920 4,249
CWIP 197 358 290 402 550 736 934 998 279 170 293 413
Investments 3 39 32 38 22 34 63 45 80 17 245 1,167
1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,425 14,620 2,142 2,284
Total Assets 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,600 8,112

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
236 203 361 537 601 1,223 1,569 1,314 1,834 158 425 656
-439 -775 -1,136 -522 -702 -658 -333 -563 -951 -878 6,015 -288
203 578 654 46 134 -675 -1,116 -686 -817 1,053 -6,358 -304
Net Cash Flow -1 5 -122 61 33 -110 120 65 66 332 82 63
Free Cash Flow -176 -536 -565 23 64 715 1,183 770 995 -601 70 179
CFO/OP 51% 53% 116% 93% 61% 88% 143% 89% 424% 40% 72% 94%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 83 93 79 84 93 100 86 72 285 23 23 24
Inventory Days 93 92 102 111 110 138 122 129 612 44 36 32
Days Payable 178 187 151 150 153 303 290 267 1,400 183 166 168
Cash Conversion Cycle -2 -1 30 45 50 -65 -83 -66 -503 -116 -107 -112
Working Capital Days 69 68 6 59 28 8 5 5 -21 272 -32 -28
ROCE % 14% 6% 1% 7% 13% 12% 6% 10% 3% 4% 11% 11%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Average Length of Stay (ALOS)
Days

Log in to view insights

Please log in to see hidden values.

Login
Average Revenue Per Occupied Bed (ARPOB)
INR
Number of Capacity Beds
Number
Number of Hospitals
Number
Occupancy Rate
%
Outpatient Visits
Million
Number of Labs and PECs
Number
Number of Pharmacies
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.89% 40.39% 40.39% 40.39% 40.39%
38.82% 40.22% 41.00% 33.48% 27.08% 23.86% 22.62% 21.66% 19.64% 18.72% 18.46% 17.18%
8.62% 7.64% 7.15% 13.70% 16.35% 20.91% 22.91% 24.58% 25.28% 26.32% 26.12% 27.57%
10.26% 9.85% 9.61% 10.59% 14.38% 13.05% 12.30% 11.60% 14.45% 14.33% 14.80% 14.61%
0.42% 0.41% 0.37% 0.35% 0.32% 0.30% 0.28% 0.26% 0.25% 0.23% 0.23% 0.23%
No. of Shareholders 71,37967,67367,33180,9312,06,6601,74,1711,59,0381,54,0141,48,1391,47,3041,46,9981,36,892

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls